Nature, Vol.566, No.7745, E11-E12, 2019
HER kinase inhibition in patients with HER2- and HER3-mutant cancers (vol 554, pg 189, 2018)
Hyman DM,
Piha-Paul SA,
Won H,
Rodon J,
Saura C,
Shapiro GI,
Juric D,
Quinn DI,
Moreno V,
Doger B,
Mayer IA,
Boni V,
Calvo E,
Loi S,
Lockhart AC,
Erinjeri JP,
Scaltriti M,
Ulaner GA,
Patel J,
Tang JB,
Beer H,
Selcuklu SD,
Hanrahan AJ,
Bouvier N,
Melcer M,
Murali R,
Schram AM,
Smyth LM,
Jhaveri K,
Li BT,
Drilon A,
Harding JJ,
Iyer G,
Taylor BS,
Berger MF,
Cutler R,
Xu F,
Butturini A,
Eli LD,
Mann G,
Farrell C,
Lalani AS,
Bryce RP,
Arteaga CL,
Meric-Bernstam F,
Baselga J,
Solit DB